Ressources

Nirmatrelvir/Ritonavir (Paxlovid): What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: février 23, 2022

Rapport personnalisé de l’ACMTS : Les répercussions de la COVID‑19 chez les Premières Nations, les Inuits et les Métis au Canada

Product: — Canadian Agency for Drugs and Technologies in Health

Ethics & Socio-cultural Socio-cultural Vulnerable Groups Vulnerable Sub-populations

covid.cadth.ca Dernière mise à jour: janvier 28, 2022

Also available in English

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 21, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 18, 2022

Mesures mises en œuvre en milieu scolaire pour contenir la pandémie de la COVID‐19

Product: — Cochrane Library

Community Prevention & Transmission Public Prevention Regulation & Policy School Protocols Vulnerable Groups Vulnerable Sub-populations

www.cochranelibrary.com Dernière mise à jour: janvier 17, 2022

Also available in English

Ontario Returns to School: An Overview of the Science

Product: — Science Table

Re-Opening School Protocols Vulnerable Groups Vulnerable Sub-populations

covid19-sciencetable.ca Dernière mise à jour: janvier 12, 2022

Fluvoxamine: What Prescribers and Pharmacists Need to Know

Product: — Science Table

Drug Interventions Healthcare Workers Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 12, 2022

Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19

Product: — Science Table

Drug Interventions Infectious Diseases & Clinical Care Practice Guidelines Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 8, 2022

Baricitinib for Hospitalized Patients with COVID-19

Product: — Science Table

Drug Interventions Hospital Care Treatments

covid19-sciencetable.ca Dernière mise à jour: janvier 8, 2022

Protecting Vulnerable Patients From the COVID‑19 Variant Omicron in Hospital

Product: — Evidence Synthesis Network

Hospital Infection Control Transmission Vulnerable Groups Vulnerable Sub-populations

esnetwork.ca Dernière mise à jour: janvier 6, 2022